Want to join the conversation?
$JBHT said that it ended 4Q15 with total debt outstanding of $1Bil on various debt instruments compared to $934MM at 4Q14 end and $993MM at 3Q15 end. The company's net capital expenditures for 2015 were about $556MM vs. $660MM in 2014. At December 31, 2015, the company had cash and cash equivalents of $5.6MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.